Huixia Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huixia Ren has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Chao Tang
Center for Quantitative Biology, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China
13 shared publications - Liangyi Chen
National Biomedical Imaging Center, College of Future Technology, Peking University, Beijing, China
7 shared publications Yanjun Li
State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, School of Future Technology, Peking University, Beijing 100871, China; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311200, Zhejiang, China
7 shared publicationsWeiran Qian
State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, School of Future Technology, Peking University, Beijing 100871, China
6 shared publicationsXiaojing Yang
Center for Quantitative Biology, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China
5 shared publicationsXiaohong Peng
State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, School of Future Technology, Peking University, Beijing 100871, China; Shenzhen University, Shenzhen 511464, China
4 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (6) , 101587
Pancreatic islet oscillation rhythmicity arises from δ and α cell interactions
- 16 April 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (6) , 101587
Open AccessPancreatic islet oscillation rhythmicity arises from δ and α cell interactions
- Open Access
- 30 March 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (5) , 101568
Glycemia shifts pancreatic islet rhythmicity by influencing interactions between δ cells and α cells
- 30 March 2026
- Published by Elsevier in Cell Systems
- Vol. 17 (5) , 101568
Open AccessGlycemia shifts pancreatic islet rhythmicity by influencing interactions between δ cells and α cells
- Open Access
Pancreatic Duct Cells as a Potential Source for Human Islet Neogenesis: Insights from Imaging Mass Cytometry
The question of whether islet neogenesis occurs in adult humans has been a subject of long-standing debate. To explore the characteristics of islet endocrine cells associated with pancreatic ducts, we employed imaging mass cytometry to examine pancreatic tissues from individuals across different age groups, including those with prediabetes or type 2 diabetes (T2D). Our analysis revealed the presence of all five pancreatic islet endocrine cell types, along with two types of non-hormone-expressing endocrine cells, located within or immediately adjacent to the ducts. These cells were most abundant in infancy, with a gradual decline observed through adulthood. Notably, ductal β cells predominated in infancy, whereas ductal α cells became more prevalent in adulthood, and significantly increased in the group aged over 60 years. Obesity further increased the ductal β cells in the subjects aged over 60 years. Under prediabetic and T2D conditions, an increase in all duct-related endocrine cells was observed. These findings indicate that ductal cells may serve as a reservoir for new pancreatic endocrine cells, offering potential insights into the promotion of endogenous β cell regeneration in diabetic patients.
Open AccessPancreatic Duct Cells as a Potential Source for Human Islet Neogenesis: Insights from Imaging Mass Cytometry
The question of whether islet neogenesis occurs in adult humans has been a subject of long-standing debate. To explore the characteristics of islet endocrine cells associated with pancreatic ducts, we employed imaging mass cytometry to examine pancreatic tissues from individuals across different age groups, including those with prediabetes or type 2 diabetes (T2D). Our analysis revealed the presence of all five pancreatic islet endocrine cell types, along with two types of non-hormone-expressing endocrine cells, located within or immediately adjacent to the ducts. These cells were most abundant in infancy, with a gradual decline observed through adulthood. Notably, ductal β cells predominated in infancy, whereas ductal α cells became more prevalent in adulthood, and significantly increased in the group aged over 60 years. Obesity further increased the ductal β cells in the subjects aged over 60 years. Under prediabetic and T2D conditions, an increase in all duct-related endocrine cells was observed. These findings indicate that ductal cells may serve as a reservoir for new pancreatic endocrine cells, offering potential insights into the promotion of endogenous β cell regeneration in diabetic patients.
- Open Access
A spatial-temporal atlas of human islet pathophysiology identifies a size-dependent trajectory from compensation to decompensation
Type 2 diabetes (T2D) is characterized by progressive islet dysfunction, yet the transition from functional adaptation to failure remains poorly defined within the native tissue architecture. Using multiplex imaging mass cytometry, we systematically analyzed human pancreatic islets across a spectrum of non-diabetic (ND), prediabetic (PreD), and T2D donors, revealing that pathological remodeling is profoundly size-dependent. This remodeling is manifested as a coordinated evolution of subpopulation abundance, endocrine cell proportions, structural integrity, and protein expression profiles, revealing that islets of different sizes undergo divergent fates during disease progression. We identified a size-dependent vulnerability spectrum where medium-and large-sized islets (>100 μm in diameter) serve as the primary histopathological correlates of glycemic failure (HbA1c), exhibiting early density loss and structural disintegration. In contrast, small islets (30-100 µm in diameter) exhibited compensatory hormone upregulation during PreD. Notably, diverging from the ‘death of the small’ paradigm in Type 1 Diabetes, our data reveal a significant expansion of extra-islet endocrine clusters (EECs) that initiates during the compensatory stage, effectively preceding the onset of overt hyperglycemia. Finally, t-SNE clustering reconstructed a continuous trajectory of islet remodeling, capturing the phenotypic evolution of islets from normoglycemia through compensation to clinical decompensation. This study provides a high-resolution atlas of islet pathophysiology, offering new insights into T2D progression. Highlights: Islet remodeling during T2D progression is critically dependent on islet size. Medium and large islets density negatively correlates with HbA1c. Small islets exhibit resilience to metabolic stress during T2D progression. EECs expansion suggests a process of α-cell-biased neogenesis. t-SNE maps the islet trajectory from compensation to decompensation.
Open AccessA spatial-temporal atlas of human islet pathophysiology identifies a size-dependent trajectory from compensation to decompensation
Type 2 diabetes (T2D) is characterized by progressive islet dysfunction, yet the transition from functional adaptation to failure remains poorly defined within the native tissue architecture. Using multiplex imaging mass cytometry, we systematically analyzed human pancreatic islets across a spectrum of non-diabetic (ND), prediabetic (PreD), and T2D donors, revealing that pathological remodeling is profoundly size-dependent. This remodeling is manifested as a coordinated evolution of subpopulation abundance, endocrine cell proportions, structural integrity, and protein expression profiles, revealing that islets of different sizes undergo divergent fates during disease progression. We identified a size-dependent vulnerability spectrum where medium-and large-sized islets (>100 μm in diameter) serve as the primary histopathological correlates of glycemic failure (HbA1c), exhibiting early density loss and structural disintegration. In contrast, small islets (30-100 µm in diameter) exhibited compensatory hormone upregulation during PreD. Notably, diverging from the ‘death of the small’ paradigm in Type 1 Diabetes, our data reveal a significant expansion of extra-islet endocrine clusters (EECs) that initiates during the compensatory stage, effectively preceding the onset of overt hyperglycemia. Finally, t-SNE clustering reconstructed a continuous trajectory of islet remodeling, capturing the phenotypic evolution of islets from normoglycemia through compensation to clinical decompensation. This study provides a high-resolution atlas of islet pathophysiology, offering new insights into T2D progression. Highlights: Islet remodeling during T2D progression is critically dependent on islet size. Medium and large islets density negatively correlates with HbA1c. Small islets exhibit resilience to metabolic stress during T2D progression. EECs expansion suggests a process of α-cell-biased neogenesis. t-SNE maps the islet trajectory from compensation to decompensation.
- Open Access
- 8 November 2025
- Published by Springer Nature in Diabetologia
- Vol. 69 (3) , 710-726
Peptide hormone spexin restores beta cell function and improves glycaemic control in mice via regulation of the sodium–potassium pump
Aims/hypothesis Clinical studies revealed that serum spexin level is positively associated with beta cell function. However, the role of spexin in beta cells remains unclear. We hypothesise that spexin treatment could influence beta cell function and modulate glucose homeostasis in vivo. Methods We analysed glucose-stimulated insulin secretion (GSIS) and beta cell proliferation in mice and isolated mouse islets. Using mice fed a high-fat diet (HFD) and an HFD/streptozocin (STZ)-induced diabetes mouse model, we investigated the effects of spexin on glucose homeostasis and beta cell function. We performed a pull-down/MS assay and a cell-based binding assay to identify the binding partner of spexin on the beta cell surface. An ion pump activity assay and Atp1a1+/− mice were used to explore the underlying regulatory mechanisms. The effects of spexin on beta cell function were further measured on isolated human islets. Results We observed that spexin treatment increased GSIS in chow-diet-fed mice and isolated mouse islets. Spexin treatment also promoted beta cell proliferation in mouse islets and pancreatectomised mice. Furthermore, spexin treatment improved glucose tolerance in HFD-fed mice and attenuated hyperglycaemia in an HFD/STZ-induced diabetes mouse model, along with an elevated serum insulin level and increased beta cell proliferation. Spexin showed specific binding to the beta cell surface. The pull-down/MS assay demonstrated that spexin bound to the α1 subunit of sodium–potassium ATPase (ATP1A1), resulting in pump activity inhibition and subsequent membrane depolarisation. In Atp1a1+/− mice, which had 50% lower levels of ATP1A1, the effects of spexin on GSIS, beta cell proliferation and hyperglycaemia decreased. Importantly, spexin-treated human islets showed increased GSIS and proliferation. Conclusions/interpretation Our study highlights that spexin is a stimulatory factor for beta cell function and proliferation, and suggests that spexin is a diabetes therapeutic target for beta cell intervention. Graphical Abstract
- 8 November 2025
- Published by Springer Nature in Diabetologia
- Vol. 69 (3) , 710-726
Open AccessPeptide hormone spexin restores beta cell function and improves glycaemic control in mice via regulation of the sodium–potassium pump
Aims/hypothesis Clinical studies revealed that serum spexin level is positively associated with beta cell function. However, the role of spexin in beta cells remains unclear. We hypothesise that spexin treatment could influence beta cell function and modulate glucose homeostasis in vivo. Methods We analysed glucose-stimulated insulin secretion (GSIS) and beta cell proliferation in mice and isolated mouse islets. Using mice fed a high-fat diet (HFD) and an HFD/streptozocin (STZ)-induced diabetes mouse model, we investigated the effects of spexin on glucose homeostasis and beta cell function. We performed a pull-down/MS assay and a cell-based binding assay to identify the binding partner of spexin on the beta cell surface. An ion pump activity assay and Atp1a1+/− mice were used to explore the underlying regulatory mechanisms. The effects of spexin on beta cell function were further measured on isolated human islets. Results We observed that spexin treatment increased GSIS in chow-diet-fed mice and isolated mouse islets. Spexin treatment also promoted beta cell proliferation in mouse islets and pancreatectomised mice. Furthermore, spexin treatment improved glucose tolerance in HFD-fed mice and attenuated hyperglycaemia in an HFD/STZ-induced diabetes mouse model, along with an elevated serum insulin level and increased beta cell proliferation. Spexin showed specific binding to the beta cell surface. The pull-down/MS assay demonstrated that spexin bound to the α1 subunit of sodium–potassium ATPase (ATP1A1), resulting in pump activity inhibition and subsequent membrane depolarisation. In Atp1a1+/− mice, which had 50% lower levels of ATP1A1, the effects of spexin on GSIS, beta cell proliferation and hyperglycaemia decreased. Importantly, spexin-treated human islets showed increased GSIS and proliferation. Conclusions/interpretation Our study highlights that spexin is a stimulatory factor for beta cell function and proliferation, and suggests that spexin is a diabetes therapeutic target for beta cell intervention. Graphical Abstract
- Open Access
- 20 September 2024
- Published by Springer Nature in Research Square
δ-α cell-to-cell interactions modulate pancreatic islet Ca2+ oscillation modes
Glucose-induced pancreatic islet hormone release is tightly coupled with oscillations in cytoplasmic free Ca2+ concentration of islet cells, which is regulated by a complex interplay between intercellular and intracellular signaling. δ cells, which entangle with α cells located at the islet periphery, are known to be important paracrine regulators. However, the role of δ cells in regulating Ca2+ oscillation pattern remains unclear. Here we show that δ-α cell-to-cell interactions are the source of variability in glucose-induced Ca2+ oscillation pattern. Somatostatin secreted from δ cells prolonged the islet’s oscillation period in an α cell mass-dependent manner. Pharmacological and optogenetic perturbations of δ-α interactions led islets to switch between fast and slow Ca2+ oscillations. Continuous adjustment of δ-α coupling strength caused the fast oscillating islets to transition to mixed and slow oscillations. We developed a mathematical model, demonstrating that the fast-mixed-slow oscillation transition is a Hopf bifurcation. Our findings provide a comprehensive understanding of how δ cells modulate islet Ca2+ dynamics and reveal the intrinsic heterogeneity of islets due to the structural composition of different cell types.
- 20 September 2024
- Published by Springer Nature in Research Square
Open Accessδ-α cell-to-cell interactions modulate pancreatic islet Ca2+ oscillation modes
Glucose-induced pancreatic islet hormone release is tightly coupled with oscillations in cytoplasmic free Ca2+ concentration of islet cells, which is regulated by a complex interplay between intercellular and intracellular signaling. δ cells, which entangle with α cells located at the islet periphery, are known to be important paracrine regulators. However, the role of δ cells in regulating Ca2+ oscillation pattern remains unclear. Here we show that δ-α cell-to-cell interactions are the source of variability in glucose-induced Ca2+ oscillation pattern. Somatostatin secreted from δ cells prolonged the islet’s oscillation period in an α cell mass-dependent manner. Pharmacological and optogenetic perturbations of δ-α interactions led islets to switch between fast and slow Ca2+ oscillations. Continuous adjustment of δ-α coupling strength caused the fast oscillating islets to transition to mixed and slow oscillations. We developed a mathematical model, demonstrating that the fast-mixed-slow oscillation transition is a Hopf bifurcation. Our findings provide a comprehensive understanding of how δ cells modulate islet Ca2+ dynamics and reveal the intrinsic heterogeneity of islets due to the structural composition of different cell types.
- Open Access
δ-α cell-to-cell interactions modulate pancreatic islet Ca2+ oscillation modes
Glucose-induced pancreatic islet hormone release is tightly coupled with oscillations in cytoplasmic free Ca2+ concentration of islet cells, which is regulated by a complex interplay between intercellular and intracellular signaling. Delta cells, which entangle with alpha cells located at the islet periphery, are known to be important paracrine regulators. However, the role of delta cells in regulating Ca2+ oscillation pattern remains unclear. Here we show that delta-alpha cell-to-cell interactions are the source of variability in glucose-induced Ca2+ oscillation pattern. Somatostatin secreted from delta cells prolonged the islet's oscillation period in an alpha cell mass-dependent manner. Pharmacological and optogenetic perturbations of delta-alpha interactions led islets to switch between fast and slow Ca2+ oscillations. Continuous adjustment of delta-alpha coupling strength caused the fast oscillating islets to transition to mixed and slow oscillations. We developed a mathematical model, demonstrating that the fast-mixed-slow oscillation transition is a Hopf bifurcation. Our findings provide a comprehensive understanding of how delta cells modulate islet Ca2+ dynamics and reveal the intrinsic heterogeneity of islets due to the structural composition of different cell types.
Open Accessδ-α cell-to-cell interactions modulate pancreatic islet Ca2+ oscillation modes
Glucose-induced pancreatic islet hormone release is tightly coupled with oscillations in cytoplasmic free Ca2+ concentration of islet cells, which is regulated by a complex interplay between intercellular and intracellular signaling. Delta cells, which entangle with alpha cells located at the islet periphery, are known to be important paracrine regulators. However, the role of delta cells in regulating Ca2+ oscillation pattern remains unclear. Here we show that delta-alpha cell-to-cell interactions are the source of variability in glucose-induced Ca2+ oscillation pattern. Somatostatin secreted from delta cells prolonged the islet's oscillation period in an alpha cell mass-dependent manner. Pharmacological and optogenetic perturbations of delta-alpha interactions led islets to switch between fast and slow Ca2+ oscillations. Continuous adjustment of delta-alpha coupling strength caused the fast oscillating islets to transition to mixed and slow oscillations. We developed a mathematical model, demonstrating that the fast-mixed-slow oscillation transition is a Hopf bifurcation. Our findings provide a comprehensive understanding of how delta cells modulate islet Ca2+ dynamics and reveal the intrinsic heterogeneity of islets due to the structural composition of different cell types.
- Open Access
- 13 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
PDX1+ cell budding morphogenesis in a stem cell-derived islet spheroid system
Remarkable advances in protocol development have been achieved to manufacture insulin-secreting islets from human pluripotent stem cells (hPSCs). Distinct from current approaches, we devised a tunable strategy to generate islet spheroids enriched for major islet cell types by incorporating PDX1+ cell budding morphogenesis into staged differentiation. In this process that appears to mimic normal islet morphogenesis, the differentiating islet spheroids organize with endocrine cells that are intermingled or arranged in a core-mantle architecture, accompanied with functional heterogeneity. Through in vitro modelling of human pancreas development, we illustrate the importance of PDX1 and the requirement for EphB3/4 signaling in eliciting cell budding morphogenesis. Using this new approach, we model Mitchell-Riley syndrome with RFX6 knockout hPSCs illustrating unexpected morphogenesis defects in the differentiation towards islet cells. The tunable differentiation system and stem cell-derived islet models described in this work may facilitate addressing fundamental questions in islet biology and probing human pancreas diseases.
- 13 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Open AccessPDX1+ cell budding morphogenesis in a stem cell-derived islet spheroid system
Remarkable advances in protocol development have been achieved to manufacture insulin-secreting islets from human pluripotent stem cells (hPSCs). Distinct from current approaches, we devised a tunable strategy to generate islet spheroids enriched for major islet cell types by incorporating PDX1+ cell budding morphogenesis into staged differentiation. In this process that appears to mimic normal islet morphogenesis, the differentiating islet spheroids organize with endocrine cells that are intermingled or arranged in a core-mantle architecture, accompanied with functional heterogeneity. Through in vitro modelling of human pancreas development, we illustrate the importance of PDX1 and the requirement for EphB3/4 signaling in eliciting cell budding morphogenesis. Using this new approach, we model Mitchell-Riley syndrome with RFX6 knockout hPSCs illustrating unexpected morphogenesis defects in the differentiation towards islet cells. The tunable differentiation system and stem cell-derived islet models described in this work may facilitate addressing fundamental questions in islet biology and probing human pancreas diseases.
- 26 January 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (2) , 238-253
Readily releasable β cells with tight Ca2+–exocytosis coupling dictate biphasic glucose-stimulated insulin secretion
Biphasic glucose-stimulated insulin secretion (GSIS) is essential for blood glucose regulation, but a mechanistic model incorporating the recently identified islet β cell heterogeneity remains elusive. Here, we show that insulin secretion is spatially and dynamically heterogeneous across the islet. Using a zinc-based fluorophore with spinning-disc confocal microscopy, we reveal that approximately 40% of islet cells, which we call readily releasable β cells (RRβs), are responsible for 80% of insulin exocytosis events. Although glucose up to 18.2 mM fully mobilized RRβs to release insulin synchronously (first phase), even higher glucose concentrations enhanced the sustained secretion from these cells (second phase). Release-incompetent β cells show similarities to RRβs in glucose-evoked Ca2+ transients but exhibit Ca2+–exocytosis coupling deficiency. A decreased number of RRβs and their altered secretory ability are associated with impaired GSIS progression in ob/ob mice. Our data reveal functional heterogeneity at the level of exocytosis among β cells and identify RRβs as a subpopulation of β cells that make a disproportionally large contribution to biphasic GSIS from mouse islets.
- 26 January 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (2) , 238-253
Readily releasable β cells with tight Ca2+–exocytosis coupling dictate biphasic glucose-stimulated insulin secretion
Biphasic glucose-stimulated insulin secretion (GSIS) is essential for blood glucose regulation, but a mechanistic model incorporating the recently identified islet β cell heterogeneity remains elusive. Here, we show that insulin secretion is spatially and dynamically heterogeneous across the islet. Using a zinc-based fluorophore with spinning-disc confocal microscopy, we reveal that approximately 40% of islet cells, which we call readily releasable β cells (RRβs), are responsible for 80% of insulin exocytosis events. Although glucose up to 18.2 mM fully mobilized RRβs to release insulin synchronously (first phase), even higher glucose concentrations enhanced the sustained secretion from these cells (second phase). Release-incompetent β cells show similarities to RRβs in glucose-evoked Ca2+ transients but exhibit Ca2+–exocytosis coupling deficiency. A decreased number of RRβs and their altered secretory ability are associated with impaired GSIS progression in ob/ob mice. Our data reveal functional heterogeneity at the level of exocytosis among β cells and identify RRβs as a subpopulation of β cells that make a disproportionally large contribution to biphasic GSIS from mouse islets.
- Open Access
- 24 November 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (47) , eadi4208
Bright and sensitive red voltage indicators for imaging action potentials in brain slices and pancreatic islets
Genetically encoded voltage indicators (GEVIs) allow the direct visualization of cellular membrane potential at the millisecond time scale. Among these, red-emitting GEVIs have been reported to support multichannel recordings and manipulation of cellular activities with reduced autofluorescence background. However, the limited sensitivity and dimness of existing red GEVIs have restricted their applications in neuroscience. Here, we report a pair of red-shifted opsin-based GEVIs, Cepheid1b and Cepheid1s, with improved dynamic range, brightness, and photostability. The improved dynamic range is achieved by a rational design to raise the electrochromic Förster resonance energy transfer efficiency, and the higher brightness and photostability are approached with separately engineered red fluorescent proteins. With Cepheid1 indicators, we recorded complex firings and subthreshold activities of neurons on acute brain slices and observed heterogeneity in the voltage‑calcium coupling on pancreatic islets. Overall, Cepheid1 indicators provide a strong tool to investigate excitable cells in various sophisticated biological systems.
- 24 November 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (47) , eadi4208
Open AccessBright and sensitive red voltage indicators for imaging action potentials in brain slices and pancreatic islets
Genetically encoded voltage indicators (GEVIs) allow the direct visualization of cellular membrane potential at the millisecond time scale. Among these, red-emitting GEVIs have been reported to support multichannel recordings and manipulation of cellular activities with reduced autofluorescence background. However, the limited sensitivity and dimness of existing red GEVIs have restricted their applications in neuroscience. Here, we report a pair of red-shifted opsin-based GEVIs, Cepheid1b and Cepheid1s, with improved dynamic range, brightness, and photostability. The improved dynamic range is achieved by a rational design to raise the electrochromic Förster resonance energy transfer efficiency, and the higher brightness and photostability are approached with separately engineered red fluorescent proteins. With Cepheid1 indicators, we recorded complex firings and subthreshold activities of neurons on acute brain slices and observed heterogeneity in the voltage‑calcium coupling on pancreatic islets. Overall, Cepheid1 indicators provide a strong tool to investigate excitable cells in various sophisticated biological systems.